Official announcements
messages in brief
|
10/03/2020
Das BASG überwacht aufmerksam gemeinsam mit der europäischen Arzneimittelagentur EMA und den nationalen Partnern der Mitgliedstaaten die möglichen Auswirkungen des Ausbruchs der neuartigen Coronavirus-Krankheit (COVID-19) auf die pharmazeutischen Lieferketten.
Safety warnings
|
Blood & Tissue
|
10/03/2020
Only available in German
Recall
|
Medicines
|
03/03/2020
Recall due to particles affecting batches 8234, 8235 und 8236
Recall
|
Medicines
|
26/02/2020
Recall due to reduced active ingredient content
messages in brief
|
13/02/2020
According to § 14 of the Federal Disability Equality Act (BGStG) Marketing authorization holders are obliged to provide their Package Leaflets in an accessible format
Safety warnings
|
Medicines
|
11/02/2020
The all-clear can be given, because samples of the active substance noscapine from manufacturer and affected pharmacies have been examined in the meantime.
Safety warnings
|
Blood & Tissue
|
11/02/2020
The Austrian Federal Office for Safety in Health Care has been informed by the European Commission about an update regarding the Novel Corona Virus (2019-nCoV).
messages in brief
|
10/02/2020
Currently, in the area of open communications, an incorrect display of the letter symbol may occur during ongoing procedures.
Incidents with extemporaneously compounded noscapine cough syrup - Usage is strongly not recommended
Safety warnings
|
Medicines
|
06/02/2020
Due to recent incidents with extemporaneously compounded products prepared noscapine cough syrup, it is recommended not to use extemporaneously compounded products noscapine cough syrup or suppositories from now on.